Experience Continuous 24/7 Therapeutic Support
At SeeBeyond Medicine, we offer Q-Restrain (Supportive Oligonucleotide Therapy) – a personalized IV-administered therapy using custom-designed oligonucleotides to powerfully activate your body’s natural defenses against cancer, chronic infections, and viruses, representing a groundbreaking advancement in precision functional medicine.
How Q-Restrain Works: Genetic Precision with Continuous Action
Q-Restrain utilizes short strands of RNA or DNA specifically designed to bind messenger RNA (mRNA) in disease-causing cells. Developed from your own blood samples, these oligonucleotides disrupt replication and survival mechanisms with exceptional specificity.
Key Mechanisms:
- Precision Genetic Targeting: Binds specific gene sequences identified through advanced blood analysis
- Autologous Design: Derived from your biological samples for minimal adverse reactions
- Continuous 24/7 Activity: Remains therapeutically active for up to six months post-IV administration
Conditions We Address: Targeted Intervention for Complex Diseases
Cancer — Solid Tumors & Blood Cancers: Q-Restrain induces apoptosis in cancer cells by targeting genes critical to their survival, complementing conventional therapies without harmful interactions.
Chronic Infections & Viruses
- Bacterial: Lyme disease (multiple strains), Babesia, Bartonella
- Viral: EBV, CMV, HSV, Hepatitis B & C, HPV, Coxsackie, HTLV-1
The Q-Restrain Process: From Diagnosis to Continuous Protection
- Diagnostic Blood Analysis RGCC laboratory testing identifies disease-specific gene sequences through advanced CTC analysis
- Therapy Design & Validation Oligonucleotides are designed in silico and validated in vitro for maximum specificity
- IV Infusion Administration 90-minute intravenous delivery provides continuous therapeutic activity for months
Safety & Eligibility: Understanding Treatment Parameters
Possible Reactions: Mild side effects may include headache, flu-like symptoms, or Herxheimer responses
Contraindications:
- Pregnancy or breastfeeding (wait periods apply)
- Recent blood transfusion (≥120 days)
- Recent chemo/radiation (14-21 days)
- Permanent exclusions: Radioactive seed therapy, GDTC therapy
Treatment Spacing:
- Cancer: Up to 4 treatments/year, spaced ≥3 months apart
- Viral/Lyme: Up to 9 treatments/year, spaced ≥21 days apart
Why Choose SeeBeyond Medicine for Q-Restrain?
Our physician-led team combines evidence-based medicine with concierge-level care:
- Personalized, science-based therapeutic design
- Minimally invasive, highly targeted approach
- Careful monitoring protocols for optimal safety and efficacy
- Integration with comprehensive functional medicine strategies
“Q-Restrain represents a paradigm shift in targeting chronic diseases at their genetic foundation. Our precision approach ensures each treatment is as unique as the individual receiving it.” — Hyun Joon Lee, MD, [Functional Medicine, Holistic and Integrative Medicine, Obesity Medicine]
Ready to Explore Q-Restrain? Contact SeeBeyond Medicine to schedule your consultation. We’ll guide you through diagnostic testing, custom therapy design, and personalized treatment planning.
Q-Restrain is not currently FDA-approved and is considered an investigational therapy. It is offered as part of our integrative medicine approach and is not intended to replace conventional cancer treatment.

